Tovar KR, Maher BJ, Westbrook GL. Direct actions of carbenoxolone on synaptic transmission and neuronal membrane properties. J Neurophysiol 102: 974 -978, 2009. First published June 17, 2009 doi:10.1152/jn.00060.2009. The increased appreciation of electrical coupling between neurons has led to many studies examining the role of gap junctions in synaptic and network activity. Although the gap junctional blocker carbenoxolone (CBX) is effective in reducing electrical coupling, it may have other actions as well. To study the non-gap junctional effects of CBX on synaptic transmission, we recorded from mouse hippocampal neurons cultured on glial microislands. This recording configuration allowed us to stimulate and record excitatory postsynaptic currents (EPSCs) or inhibitory postsynaptic currents (IPSCs) in the same neuron or pairs of neurons. CBX irreversibly reduced evoked ␣-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptor-mediated EPSCs. Consistent with a presynaptic site of action, CBX had no effect on glutamate-evoked whole cell currents and increased the paired-pulse ratio of AMPA and Nmethyl-D-aspartate (NMDA) receptor-mediated EPSCs. CBX also reversibly reduced GABA A receptor-mediated IPSCs, increased the action potential width, and reduced the action potential firing rate. Our results indicate CBX broadly affects several neuronal membrane conductances independent of its effects on gap junctions. Thus effects of carbenoxolone on network activity cannot be interpreted as resulting from specific block of gap junctions.
I N T R O D U C T I O N
Electrical coupling can synchronize the activity of coupled neurons. Although the properties of gap junction proteins such as connexins and their expression in neurons are now well documented (Connors and Long 2004; Nagy et al. 2004) , the impact of electrical coupling on neuronal ensembles or networks is still being explored. Although synchronization of membrane voltage by action potentials (Landisman et al. 2002) or subthreshold depolarizations (Long et al. 2004 ) can distribute and propagate concerted signals in electrically coupled networks, network activity involves a complex mixture of receptors, channels and intrinsic membrane properties. Thus elucidating the role of gap junctions and electrical coupling requires tools that reliably and specifically block gap junctions. One of the most commonly used gap junction blockers is the glycyrrhetinic acid derivative carbenoxolone (CBX). CBX eliminates electrical and gap junctional coupling in several experimental systems (Martin et al. 1991; Schoppa and Westbrook 2002; Zsiros and Maccaferri 2005) . However, in our prior experiments in brain slices, CBX seemed to alter synaptic transmission independently of gap junction block (Schoppa and Westbrook 2002) . Here, we examined whether CBX directly affected synaptic transmission and action potential firing by using whole cell voltage-and current-clamp recording in mouse hippocampal neurons cultured on glial micro-islands.
M E T H O D S

Cell culture
Micro-island cultures were prepared using the method of Bekkers and Stevens (1991) . Round glass coverslips (15 mm; Bellco Glass) were coated with 0.15% agarose, allowed to dry, and sprayed with a solution containing poly-D-lysine (0.1 mg/ml) and collagen (0.375 mg/ml) in 17 mM acetic acid. Hippocampi dissected from P0 to P1 mice (C57BL/6) were incubated in a papain solution (200 units; Worthington Biochemical) for 30 min (35°C), and the papain was inactivated in complete media containing bovine serum albumin (2.5 mg/ml) and trypsin inhibitor (2.5 mg/ml). The tissue was triturated with fire-polished Pasteur pipettes, and individual cells in suspension were counted using a hemocytometer. To make glial micro-islands, cells were plated at 100,000 cells per 35-mm dish (Nunc). To grow neurons on prepared glial micro-islands, cells were plated at 25,000 cells per 35-mm dish. All cultured cells were grown in 3 ml of complete media. Media contained 5% heat-inactivated fetal bovine serum (Lonza). Media was replaced weekly by removing 1.5 ml of media per dish and replacing it with the same volume of freshly prepared media.
Electrophysiology
For whole cell voltage-clamp recordings, we used neurons that were 6 -15 days in vitro (DIV). Micro-islands were perfused by gravity flow with extracellular solution containing (in mM) 168 NaCl 2 , 2.4 KCl, 10 HEPES, 10 glucose, and 1.3 CaCl 2 (pH 7.4; 325 mOsm). Recording electrodes were pulled from borosilicate glass (World Precision Instruments, Sarasota, FL) and had resistances of 2.5-5 M⍀. Recording electrodes were filled with a solution containing (in mM) 140 K-gluconate, 6.23 CaCl 2 , 8 NaCl, 2 MgCl 2 , 10 EGTA, 10 HEPES, 2 Na 2 ATP, and 0.1 Na 2 GTP (pH 7.4; 320 mOsm). All recordings were at room temperature using Axopatch 1C amplifiers and AxoGraph acquisition software (AxographX, Sydney, Australia). Series resistance was always Ͻ10 M⍀ and was compensated by Ն80% by the amplifier circuitry. Data were low-pass filtered at 5 kHz and acquired at 10 kHz. The membrane voltage was held at Ϫ70 mV. Brief (0.5-1 ms) depolarizations to 20 mV triggered unclamped action potentials in the axon, and evoked voltage-clamped synaptic currents in the dendrite. Neurons were stimulated at low frequency (0.1-0.133 Hz).
For current-clamp experiments, we first patched onto the neuron in voltage-clamp mode and determined whether the neuron was excitatory or inhibitory by evoking postsynaptic currents as described above. We then bathed the recorded neuron in NBQX (5 M), D-AP5 (100 M) or D-CPP (5-10 M), and SR 95531 (10 M) to block AMPA, NMDA, and GABA A receptors, respectively. For current-clamp experiments, the membrane voltage was maintained near Ϫ65 mV by small current injections (Ϯ20 pA).
CBX was solubilized in water and stored as a 50 M stock solution at 4°C for no longer than 4 wk. For all experiments, drugs were applied via gravity-fed flowpipes positioned 50 -200 M away from recorded neurons. The flowpipes were attached to a piezo-electric bimorph for fast exchange of agonists or antagonists.
Data analysis
We used AxographX analysis software for all analyses. We measured input resistance from voltage-clamp records and repolarization potentials after the first spike. All data were compared using ANOVA or paired Student's t-test with significance set at P Ͻ 0.05. Data are reported as mean Ϯ SE.
R E S U L T S
Carbenoxolone and synaptic function
We tested CBX at concentrations (50 -100 M) commonly used to block gap junctions in brain slices (Schoppa and Westbrook 2002; Zsiros and Maccaferri 2005) . CBX (100 M) reduced AMPA receptor-mediated EPSCs to 63.3 Ϯ 4.5% of the control amplitude (n ϭ 28). The onset of the EPSC reduction was fast, occurring within the 7.5-s interstimulus interval (Fig. 1C, left) . Lower concentrations of CBX also reduced EPSC amplitudes (80.0 Ϯ 2.2, n ϭ 10 and 79.2 Ϯ 3.3, n ϭ 14 for 10 and 50 M, respectively; Fig. 1, A and B) . Recovery of the EPSC amplitude after removal of CBX was incomplete and thus prevented us from examining the doseresponse relationship on single cells. Although 50 M CBX was marginally less effective than 100 M when comparing groups of cells, increasing the CBX concentration from 50 to 100 M CBX on an individual cell did not produce further inhibition (Fig. 1C, right) .
To test whether CBX had a direct postsynaptic effect on AMPA receptors, we applied glutamate (500 M) in the presence of 0.5 M TTX, 10 M SR-95531 and 100 M D-AP5 or 5 M D-CPP. The flowpipes used for drug applications were translated using a piezo-electric bimorph. As shown in Fig. 1D , CBX (100 M) did not reduce whole cell glutamate-activated currents (95.7 Ϯ 1.2% of the control amplitude, n ϭ 5) indicating that CBX did not directly inhibit AMPA receptors.
The above results suggest that the reduction of the AMPA receptor-mediated EPSC involves a presynaptic mechanism. Consistent with this possibility, CBX increased the pairedpulse ratio (PPR) of AMPA receptor-mediated EPSCs. The ratio of the second EPSC to the first (P2/P1; 50-ms interstimulus interval) was 1.38 Ϯ 0.12 in CBX (100 M) compared with 1.19 Ϯ 0.08 in control (P Ͻ 0.01, n ϭ 17; Fig. 2, A and B) . 50 M CBX also increased the AMPA PPR (0.94 Ϯ 0.07 in control; 1.05 Ϯ 0.06 in CBX, n ϭ 14, P Ͻ 0.005; data not shown). As expected for a presynaptic mechanism, the extent of block of the EPSC by CBX (100 M) correlated with its effect on the PPR (r ϭ 0.78). However, there was no relationship between the control PPR and the extent of block (r ϭ 0.23 for 100 M CBX and r ϭ 0.02 for 50 M CBX), indicating that all the synapses were susceptible to CBX inhibition.
AMPA and NMDA receptors co-localize at most postsynaptic sites in central neurons ( Baughman 1991). As predicted for a presynaptic locus of action, CBX also irreversibly reduced NMDA receptor-mediated EPSCs (Fig. 2C) . In CBX (100 M), the NMDA receptor-mediated EPSC was reduced to 69.1 Ϯ 3.2% of control (n ϭ 14), and PPR increased ( Fig. 2D; 1 .78 Ϯ 0.13 in CBX, 1.41 Ϯ 0.04 in control, n ϭ 14, P Ͻ 0.01). CBX also reduced the amplitude of GABA A receptor-mediated IPSCs. In 10, 50, or 100 M CBX, peak IPSCs were reduced by 81.2 Ϯ 3.9 (n ϭ 3), 60.0 Ϯ 6.7 (n ϭ 4), and 49.8 Ϯ 5.7% (n ϭ 7) of control (Fig. 3, A and B) . Unlike the reduction in EPSCs, the inhibition of GABA A IPSCs was rapidly and fully reversible and did not affect the PPR (0.71 Ϯ 0.04 for control; 0.68 Ϯ 0.05 for 100 M CBX, n ϭ 7).
Effects on action potentials and repetitive firing
To evoke synaptic currents, we used brief depolarizing voltage injections that triggered an unclamped action potential in the axon. In the soma, the resulting action current was followed by an evoked synaptic current (Fig. 1A) . In the presence of CBX, we noticed a consistent increase in the width of the action currents. We examined this issue in greater detail by evoking action potentials in current clamp in the presence of AMPA, NMDA, and GABA A receptor antagonists.
Consistent with our observations using voltage clamp, CBX increased the width of action potentials evoked by current pulses by 11.4 Ϯ 1.9% (n ϭ 7; P Ͻ 0.005; 50 M) and 24.5 Ϯ 2.9% (n ϭ 8; P Ͻ 0.00005; 100 M; Fig. 4, A and B) . During long current injections, action potentials in control and CBX gradually accommodated (Fig. 4C) . However, neurons in CBX fired fewer action potential during a 200-ms current injection. The reduction in the number of action potentials was 1.8 Ϯ 0.48 (n ϭ 7; P Ͻ 0.01) for 50 M CBX and 2.6 Ϯ 0.57 (n ϭ 9; P Ͻ 0.01) for 100 M CBX (Fig. 4D) . In our experiments, 10 M CBX did not affect action potential width or the number of action potentials (data not shown). As shown in Fig. 4E , the interval between the first and second spike was increased to 56.1 Ϯ 13.8 ms in 100 M CBX compared with 27.4 Ϯ 4.2 ms in control (n ϭ 7; P Ͻ 0.05). CBX at 10 or 50 M did not affect the first interspike interval (data not shown). The maximum hyperpolarization after the first spike (repolarization potential) was 1.1 Ϯ 0.4 mV more depolarized in CBX (100 M) than in control (n ϭ 8, P Ͻ 0.05). The effects on spike width and the repolarization potential are consistent with a reduction of potassium conductances that repolarize the membrane. CBX (100 M) also decreased the resting membrane input resistance by 20.6% (134.9 Ϯ 15.1 M⍀ control compared with 107.1 Ϯ 12.5 M⍀ in CBX, n ϭ 24; P Ͻ 0.001). Thus in excitatory hippocampal neurons, CBX affects membrane conductances that are active at the resting membrane potential as well as voltage-dependent potassium conductances involved in action potential repolarization.
D I S C U S S I O N
Our results showed that the commonly used gap junction blocker CBX has a broad range of non-gap junctional actions, including a reduction in excitatory and inhibitory synaptic currents, attenuation of membrane repolarization and spike rate, and decreases in input resistance. We focused on excitatory neurons from the mouse hippocampus, a relatively homogenous cell group. However, CBX had similar actions on GABAergic interneurons, strongly suggesting that our results are not limited to specific cell types.
We applied CBX in the same concentration range necessary to block gap junctions. CBX affected synaptic transmission at concentrations as low as 10 M, whereas the effects on action potentials required Ն50 M. Cultured neurons generally provide greater access to drug applications than brain slices. For example, the non-gap junctional actions of CBX occurred within a few seconds in our experiments. Equilibration is slower in brain slices, but the concentration at neuronal membranes should reach similar levels within the tens of minutes used in brain slice perfusion of drugs. CBX is membrane permeant (Monder et al. 1989 ) and will diffuse readily across 2. AMPA receptor-mediated EPSC reduction results from a presynaptic effect of CBX. We used the paired-pulse ratio (PPR) to assess the release probability. A: pairs of AMPA receptor-mediated EPSCs were stimulated at 50-ms interpulse intervals. We normalized the first EPSC of the pair to show that CBX reduced the 2nd EPSC to a lesser extent than the 1st EPSC. B: the PPR of the AMPA receptor-mediated EPSC was higher in CBX (100 M) compared with control, consistent with a presynaptic site of action. C: NMDA receptor-mediated EPSCs (in 5 M NBQX to block AMPA receptors) were also reduced by CBX (100 M) as shown in this recording (50-ms interstimulus interval) D: similar to AMPA receptor-mediated EPSCs, normalizing the 1st EPSC showed that the 2nd EPSC was reduced less by CBX (50-ms interstimulus interval). membranes, perhaps aiding access but delaying recovery. Thus this drug cannot be reliably used to indicate a role for gap junctions in complex physiological responses such as network activity. Although CBX generally reduced excitatory transmission, the reduction in inhibitory transmission could lead under appropriate circumstances to net increases in network activity.
The molecular basis of the broad effects of CBX is not clear. CBX (18-␤-glycyrrhetinic acid sodium hemisuccinate) is a water-soluble derivative of a compound from licorice root, which has a steroid-like structure (Davidson and Baumgarten 1988) . Other steroid-like molecules can duplicate the effect of CBX on gap junctions (Davidson and Baumgarten 1988; Davidson et al. 1986 ), although neurosteroids like aldosterone (50 M), prednisolone (100 M), hydrocortisone (100 M), or cholesterol (100 M) did not block gap junctions in cultured human fibroblasts (Davidson et al. 1986 ). The incomplete reversibility of AMPA receptor-mediated EPSC inhibition likely reflects a large number of nonspecific membrane binding sites that slow CBX clearance. Calcium channels are the most likely presynaptic target causing the reduction in release probability in excitatory neurons. For example, CBX can block calcium channels in retinal cone photoreceptors (Vessey et al. 2004) . Our results confirm and extend prior reports of gap junction-independent effects of CBX on membrane properties of hippocampal neurons (Rekling et al. 2000; Rouach et al. 2003) . Although Rouach et al. (2003) saw no effect of CBX on the frequency of miniature EPSCs, our results clearly indicate that CBX can affect evoked release of glutamate. Rouach et al. (2003) reported a reversible effect of CBX on spike threshold, whereas only the block of GABA A IPSCs was completely reversible in our experiments. Our results also indicate that the actions of CBX cannot be attributed to one type of ion channel.
CBX is effective in blocking gap junctions when assessed in isolation. However, our results and those of others (Chepkova et al. 2008; Rekling et al. 2000; Rouach et al. 2003; Vessey et al. 2004) indicate that CBX acts on multiple membrane conductances and thus should not be used to assess the role of gap junctions on network activity. Given the gap junctionindependent effects of CBX, studies that used CBX exclusively to infer the role of gap junctions in epileptiform activity 
